Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as capecitabine and oxaliplatin, work in
different ways to stop the growth of tumor cells, either by killing the cells or by stopping
them from dividing.
PURPOSE: This phase II trial is studying how well giving capecitabine together with
oxaliplatin works in treating older patients with metastatic colorectal cancer.